# Eli Lilly and Company (LLY): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Eli Lilly and Company (LLY) is 82/100, ranked against 24,000+ stocks in 35 markets (Quality 80, Value 20, Momentum 77, each scored against its sector).

- StockRank: 82/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 80, Value 20, Momentum 77: each a 0-100 percentile within the stock's sector.
- Position: #4,944 overall, #552 in Healthcare.
- Listing: United States, NYQ; Healthcare / Drug Manufacturers - General.
- Last close: 1,182.62 USD on 12 Oct 2026.
- Insider filings, last 180 days: directors sold USD 18.8M.
- Buybacks, last 180 days: the company bought back USD 5.8B on 2 days.

Source: https://moatmap.ai/stock/LLY
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker